Cited In for PMID: 19625712

Year	Number of Results
2009	7
2010	33
2011	44
2012	60
2013	54
2014	52
2015	44
2016	29
2017	24
2018	12
2019	11
2020	7
2021	7
2022	8
2023	2
2024	1

1

Peginterferon alfa-2b or alfa-2a with ribavirin for treatment of hepatitis C infection.

McHutchison JG, Lawitz EJ, Shiffman ML, Muir AJ, Galler GW, McCone J, Nyberg LM, Lee WM, Ghalib RH, Schiff ER, Galati JS, Bacon BR, Davis MN, Mukhopadhyay P, Koury K, Noviello S, Pedicone LD, Brass CA, Albrecht JK, Sulkowski MS; IDEAL Study Team. McHutchison JG, et al. N Engl J Med. 2009 Aug 6;361(6):580-93. doi: 10.1056/NEJMoa0808010. Epub 2009 Jul 22. N Engl J Med. 2009. PMID: 19625712 Free article. Clinical Trial.

2

Portal Vein Aneurysm in a Patient with Cirrhosis Type C Controlled by Direct-Acting Antiviral Treatment.

Higashi S, Nakabori T, Mukai K, Seiki Y, Watsuji K, Hirao T, Kawamoto Y, Urabe M, Kai Y, Takada R, Yamai T, Ikezawa K, Uehara H, Ohkawa K. Higashi S, et al. Case Rep Gastroenterol. 2024 Feb 16;18(1):74-80. doi: 10.1159/000535957. eCollection 2024 Jan-Dec. Case Rep Gastroenterol. 2024. PMID: 38371742 Free PMC article.

3

Hepatitis Virus-associated Non-hodgkin Lymphoma: Pathogenesis and Treatment Strategies.

Zhang W, Du F, Wang L, Bai T, Zhou X, Mei H. Zhang W, et al. J Clin Transl Hepatol. 2023 Oct 28;11(5):1256-1266. doi: 10.14218/JCTH.2022.00079S. Epub 2023 May 30. J Clin Transl Hepatol. 2023. PMID: 37577221 Free PMC article. Review.

4

Real-world impact of a subsidy decision of sofosbuvir-velpatasvir for treatment of chronic hepatitis C on clinical practice and patient outcomes.

Tan CK, Luo XS, Ong BS, Lin L, Ng KH. Tan CK, et al. JGH Open. 2022 Nov 29;7(1):48-54. doi: 10.1002/jgh3.12850. eCollection 2023 Jan. JGH Open. 2022. PMID: 36660045 Free PMC article.

5

Chronic Hepatitis C: Pathophysiology and Clinical Issues.

Abate ML, Caviglia GP. Abate ML, et al. Biology (Basel). 2022 Nov 29;11(12):1737. doi: 10.3390/biology11121737. Biology (Basel). 2022. PMID: 36552247 Free PMC article.

6

HCV infection characteristics, treatment uptake and outcomes in patient with diabetes mellitus.

Angel M, Petrosyan Y, Doyle MA, Cooper C. Angel M, et al. BMC Endocr Disord. 2022 Nov 12;22(1):277. doi: 10.1186/s12902-022-01198-x. BMC Endocr Disord. 2022. PMID: 36371200 Free PMC article.

7

Cost-effectiveness of direct-acting antivirals for chronic hepatitis C virus in the United States from a payer perspective.

Kaplan DE, Serper M, Kaushik A, Durkin C, Raad A, El-Moustaid F, Smith N, Yehoshua A. Kaplan DE, et al. J Manag Care Spec Pharm. 2022 Oct;28(10):1138-1148. doi: 10.18553/jmcp.2022.28.10.1138. J Manag Care Spec Pharm. 2022. PMID: 36125059 Free PMC article.

8

Real-world health care utilization in treatment of HCV: Results from the Canadian SIMPLE observational trial.

Tam E, Borgia S, Yoshida EM, Cooper C, Ford JA, Vachon ML, Sherman M, Halsey-Brandt J. Tam E, et al. Can Liver J. 2019 Aug 27;2(3):91-107. doi: 10.3138/canlivj.2018-0024. eCollection 2019 Summer. Can Liver J. 2019. PMID: 35990217 Free PMC article.

9

Breakthroughs in hepatitis C research: from discovery to cure.

Manns MP, Maasoumy B. Manns MP, et al. Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):533-550. doi: 10.1038/s41575-022-00608-8. Epub 2022 May 20. Nat Rev Gastroenterol Hepatol. 2022. PMID: 35595834 Free PMC article. Review.

10

Hepatitis C Virus NS3/4A Inhibition and Host Immunomodulation by Tannins from Terminalia chebula: A Structural Perspective.

Patil VS, Harish DR, Vetrivel U, Roy S, Deshpande SH, Hegde HV. Patil VS, et al. Molecules. 2022 Feb 5;27(3):1076. doi: 10.3390/molecules27031076. Molecules. 2022. PMID: 35164341 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

352 results

Results by year